Jack Anders, Chief Financial Officer at Revolution Medicines, Inc. (RVMD), sold 20,000 shares at $40.17 ($802K) on 2025-09-03, disclosed to the SEC on 2025-09-04.
Scheduled sale ($802k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.02 | 4,762 | $191K | 23.8% |
| 2 | $40.02 | 4,762 | $191K | 23.8% |
| 3 | $40.17 | 5,238 | $210K | 26.2% |
| 4 | $40.17 | 5,238 | $210K | 26.2% |
| Total | $40.10 avg | 20,000 | $802K | 100% |
| Filing → |
| RVMD | SELL | 2026-06-18 | $425K | — | Filing → |
| RVMD | SELL | 2026-03-19 | $548K | — | Filing → |
| RVMD | SELL | 2026-01-09 | $980K | — | Filing → |